Skip to main content

Advertisement

Open Peer Review Reports for: FRAX597, a PAK1 inhibitor, synergistically reduces pancreatic cancer growth when combined with gemcitabine

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
12 Aug 2015 Submitted Original manuscript
21 Aug 2015 Reviewed Reviewer Report - Sebastian Krug
2 Sep 2015 Reviewed Reviewer Report - Motoyoshi Tanaka
3 Sep 2015 Reviewed Reviewer Report - Sven Lang
6 Oct 2015 Author responded Author comments - Dannel Yeo
Resubmission - Version 2
6 Oct 2015 Submitted Manuscript version 2
10 Oct 2015 Reviewed Reviewer Report - Motoyoshi Tanaka
16 Oct 2015 Reviewed Reviewer Report - Sebastian Krug
24 Oct 2015 Reviewed Reviewer Report - Sven Lang
24 Dec 2015 Author responded Author comments - Dannel Yeo
Resubmission - Version 3
24 Dec 2015 Submitted Manuscript version 3
Publishing
8 Jan 2016 Editorially accepted
16 Jan 2016 Article published 10.1186/s12885-016-2057-z

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement